Literature DB >> 8948307

A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.

G Myklebust1, J T Gran.   

Abstract

A prospective study of 287 patients with giant cell arteritis (GCA), including polymyalgia rheumatica (PMR) and temporal arteritis (TA), was conducted during 1987-1994. All patients were evaluated prior to the start of drug treatment. During the same period, 31 patients with GCA, of whom 12 cases had TA, were admitted to other departments in the hospital. At onset of disease, all patients were > or = 50 yr of age. Peripheral arthritis was found in 24.4% of patients with PMR, while none of the patients with TA exhibited such manifestations. Clinical features at onset of disease differed from those appearing at presentation to the hospital. Thus, the gradual development of a full-blown clinical picture may be responsible for the delay in diagnosis of GCA. The majority of cases (80%) presented with "pure' PMR without clinical signs or symptoms of concomitant TA. In a random sample of 68 patients with "pure' PMR, histological examinations of biopsy specimens of the temporal artery revealed inflammatory changes in three patients only (4.4%). Consequently, arterial biopsy in patients with clinical features of PMR only, appears to be unnecessary. Among patients with TA referred to the department of internal medicine, general malaise, loss of weight and sustained fever were prominent manifestations. Such features may thus necessitate a diagnostic arterial biopsy even in the absence of clinical arteritis or myalgia. Both ESR and CRP were within normal levels in 1.2% of the cases. Further clinical and laboratory examinations performed at diagnosis of GCA disclosed only one case of malignancy. Routine chest X-rays did not reveal unexpected pathological findings. Permanent and complete blindness due to arteritis was observed in one patient only. No association between GCA and thyroid dysfunction was detected.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948307     DOI: 10.1093/rheumatology/35.11.1161

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  30 in total

Review 1.  Rheumatology: 2. What laboratory tests are needed?

Authors:  K Shojania
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

Review 2.  [What should be done in weight loss of unknown origin?].

Authors:  A Schwenk
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 3.  Recent advances in diagnostic strategies for giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  Giant cell arteritis with normal ESR and/or CRP is rare, but not unique!

Authors:  A Grzybowski; A Justynska
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

5.  Response to Grzybowski and Justynska.

Authors:  S L Levy; A D Bull; A R Nestel
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

Review 6.  [Large vessel vasculitis].

Authors:  L Caspary; S Schellong
Journal:  Internist (Berl)       Date:  2009-08       Impact factor: 0.743

7.  Association between giant cell arteritis and thyroid dysfunction in a "real life" population.

Authors:  Yarden Yavne; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Endocrine       Date:  2017-06-16       Impact factor: 3.633

8.  The process from symptom onset to rheumatology clinic in polymyalgia rheumatica.

Authors:  Ediz Dalkılıç; Ayşe Nur Tufan; Emre Hafızoğlu; Merve Hafızoğlu; Fatih Tufan; Ferhat Oksuz; Yavuz Pehlivan; Mustafa Yurtkuran
Journal:  Rheumatol Int       Date:  2014-05-11       Impact factor: 2.631

9.  A case of polyarteritis nodosa presenting initially as peripheral vascular disease.

Authors:  Serge De Golovine; Sameer Parikh; Lee Lu
Journal:  J Gen Intern Med       Date:  2008-06-17       Impact factor: 5.128

Review 10.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.